Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
LUDWIGSHAFEN, GERMANY: Effective September 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and generic active pharmaceutical ingredients by 10 per cent. Due to the continued rise in costs for raw materials, energy and labour this price increase has become necessary. All existing contractual obligations will be honoured.
This price increase affects the entire excipients portfolio including all binders, disintegrants, coatings, solubilizers, and solvents. The affected generic active pharmaceutical ingredient (API) portfolio contains products like Ibuprofen, Caffeine, and Pseudoephedrine.
(C) WOC News
Login
· Refining industry under pressure to cut costs. · Chevron merged petrochem/refining arms last year. PARIS, FRANCE: ...
MUMBAI, INDIA: Mukesh Ambani led Reliance Industries Limited (RIL), has decided to bring in Navin Wadhwani, Ex-Managing Director at NM Rothsch ...
PARIS, FRANCE: Air Liquide said its engineering and construction division has signed a contract with Shenhua Ningxia Coal Industry Group in Ch ...
PITTSBURGH, US: PPG Industries has signed a letter of intent with Harsha Exito Engineering Pvt Ltd (India) to establish a 50-50 joint venture ...
NEW HAVEN, US: Yale University researchers have successfully re-engineered the protein-making machinery in bacteria, a technical tour de force ...
AKRON, US: Geckos’ ability to scamper up walls with ease has long inspired scientists who study the fine keratin hairs on these creature ...
Stay updated with the latest chemical industry trends and innovations.